Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2
Open Access
- 29 October 2021
- Vol. 13 (11), 2183
- https://doi.org/10.3390/v13112183
Abstract
Rapid antigen tests (RATs) for COVID-19 based on lateral flow immunoassays are useful for rapid diagnosis in a variety of settings. Although many kinds of RATs are available, their respective sensitivity has not been compared. Here, we examined the sensitivity of 27 RATs available in Japan for the detection of the SARS-CoV-2 delta variant. All of the RATs tested detected the delta variant albeit with different sensitivities. Nine RATs (ESPLINE SARS-CoV-2, ALSONIC COVID-19 Ag, COVID-19 and Influenza A+B Antigen Combo Rapid Test, ImmunoArrow SARS-CoV-2, Fuji Dri-chem immuno AG cartridge COVID-19 Ag, 2019-nCoV Ag rapid detection kit, Saliva SARS-CoV-2(2019-nCoV) Antigen Test Kit, and Rabliss SARS-CoV-2 antigen detection kit COVID19 AG) showed superior sensitivity to the isolated delta variant. Although actual clinical specimens were not examined, the detection level of most of the RATs was 7500 pfu, indicating that individuals whose test samples contained less virus than that would be considered negative. Therefore, it is important to bear in mind that RATs may miss individuals shedding low levels of infectious virus.Keywords
Funding Information
- Japan Agency for Medical Research and Development (JP21wm0125002)
- National Institute of Allergy and Infectious Diseases (CRIP; HHSN272201400008C)
This publication has 26 references indexed in Scilit:
- Development of Genetic Diagnostic Methods for Detection for Novel Coronavirus 2019(nCoV-2019) in JapanJapanese Journal of Infectious Diseases, 2020
- Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal SwabsJournal of Clinical Microbiology, 2020
- Interpreting Diagnostic Tests for SARS-CoV-2JAMA, 2020
- Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospitalJournal of Clinical Virology, 2020
- Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosisJournal of Clinical Virology, 2020
- Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cellsProceedings of the National Academy of Sciences of the United States of America, 2020
- Sensitivity of Commercially Available Influenza Rapid Diagnostic Tests in the 2018–2019 Influenza SeasonFrontiers in Microbiology, 2019
- Reactivity and sensitivity of commercially available influenza rapid diagnostic tests in JapanScientific Reports, 2017
- Detection sensitivity of influenza rapid diagnostic testsMicrobiology and Immunology, 2014
- Sensitivity of Influenza Rapid Diagnostic Tests to H5N1 and 2009 Pandemic H1N1 VirusesJournal of Clinical Microbiology, 2010